Influence of BMI on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML

被引：0
|
作者：
Burhani, Mansoor [1 ]
Dave, Manish J. [1 ]
Venugopal, Parameswaran [1 ]
Larson, Melissa L. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7106
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Importance of albumin level on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML.
    Burhani, Mansoor
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    Schlenk, RF
    Germing, U
    Hartmann, F
    Glasmacher, A
    Fischer, JT
    Fuentes, FDY
    Götze, K
    Pralle, H
    Nerl, C
    Salwender, H
    Grimminger, W
    Petzer, A
    Hensel, M
    Benner, A
    Zick, L
    Döhner, K
    Fröhling, S
    Döhner, H
    LEUKEMIA, 2005, 19 (06) : 978 - 983
  • [4] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    R F Schlenk
    U Germing
    F Hartmann
    A Glasmacher
    J T Fischer
    F del Valle y Fuentes
    K Götze
    H Pralle
    C Nerl
    H Salwender
    W Grimminger
    A Petzer
    M Hensel
    A Benner
    L Zick
    K Döhner
    S Fröhling
    H Döhner
    Leukemia, 2005, 19 : 978 - 983
  • [5] A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML
    Schwarer, Anthony P.
    Butler, Jason
    Jackson, Kathryn
    Beligaswatte, Ashanka
    Martin, Louisa
    Kennedy, Glen
    Daniela, Zantomio
    Lewis, Ian
    Hiwase, Devendra
    Wight, Joel
    He, Simon
    Grigg, Andrew
    Morris, Kirk
    Mollee, Peter
    Marlton, Paula
    HEMASPHERE, 2018, 2 (06):
  • [6] High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).
    Larson, Sarah
    Campbell, Nicholas
    Huo, Dezheng
    Artz, Andrew
    Zhang, Yanming
    Gajria, Devika
    Green, Margaret
    Rahimova, Gamar
    Weiner, Howard
    Torres, Monica
    Odenike, Olatoyosi
    Godley, Lucy A.
    Rich, Elizabeth Shima
    Thirman, Michael
    Larson, Richard A.
    Stock, Wendy
    BLOOD, 2009, 114 (22) : 434 - 434
  • [7] SHORT COURSE HIGH-DOSE MITOXANTRONE WITH HIGH-DOSE CYTARABINE IS EFFECTIVE THERAPY FOR ADULT LYMPHOBLASTIC-LEUKEMIA
    ARLIN, ZA
    FELDMAN, EJ
    FINGER, LR
    AHMED, T
    MITTELMAN, A
    COOK, P
    PUCCIO, C
    BASKIND, P
    ARNOLD, P
    RAZIS, ED
    DECTER, J
    CHUN, HG
    LEUKEMIA, 1991, 5 (08) : 712 - 714
  • [8] Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)
    Creutzig, Ursula
    Zimmermann, Martin
    Bourquin, Jean-Pierre
    Dworzak, Michael N.
    von Neuhoff, Christine
    Sander, Annette
    Schrauder, Andre
    Teigler-Schlegel, Andrea
    Stary, Jan
    Corbacioglu, Selim
    Reinhardt, Dirk
    BLOOD, 2011, 118 (20) : 5409 - 5415
  • [9] Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable
    Wang, Amy Y.
    Weiner, Howie Lawrence
    Green, Margaret
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew
    Godley, Lucy A.
    Thirman, Michael J.
    Churpek, Jane E.
    Curran, Emily K.
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    BLOOD, 2016, 128 (22)
  • [10] The role of high-dose cytarabine in induction therapy for adult ALL
    Gökbuget, N
    Hoelzer, D
    LEUKEMIA RESEARCH, 2002, 26 (05) : 473 - 476
12345